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Background: Though it is well established that neonatal nutrition plays a major role in lifelong 29 
offspring health, the mechanisms underpinning this have not been well defined. Early postnatal 30 
accelerated growth resulting from maternal nutritional status is associated with increased 31 
appetite and body weight. Likewise, slow growth correlates with decreased appetite and body 32 
weight. Food consumption and food-seeking behaviour are directly modulated by central 33 
serotonergic (5-hydroxytryptamine, 5-HT) pathways. This study examined the effect of a rat 34 
maternal postnatal low protein (PLP) diet on 5-HT receptor mediated food intake in offspring. 35 
Methods: Microarray analyses, in situ hybridization or laser capture microdissection of the 36 
ARC followed by RT-PCR were used to identify genes up- or down-regulated in the arcuate 37 
nucleus of the hypothalamus (ARC) of 3-month-old male PLP rats. Third ventricle cannulation 38 
was used to identify altered sensitivity to serotonin receptor agonists and antagonists with 39 
respect to food intake. 40 
Results: Male PLP offspring consumed less food and had lower growth rates up to 3 months 41 
of age compared to Control offspring from dams fed a normal diet. 97 genes were 42 
upregulated (including the 5-HT5A receptor (5-HT5AR) and 149 downregulated genes in PLP 43 
rats compared to Controls. The former obesity medication fenfluramine and the 5-HT 44 
receptor agonist 5-Carboxamidotryptamine (5-CT) significantly suppressed food intake in 45 
both groups, but the PLP offspring were more sensitive to d-fenfluramine and 5-CT 46 
compared to Controls. The effect of 5-CT was antagonized by the 5-HT5AR antagonist 47 
SB699551. 5-CT also reduced NPY-induced hyperphagia in both Control and PLP rats but 48 
was more effective in PLP offspring. 49 
Conclusions: Postnatal low protein programming of growth in rats enhances the central effects 50 
of serotonin on appetite by increasing hypothalamic 5-HT5AR expression and sensitivity. These 51 
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findings provide insight into the possible mechanisms through which a maternal low protein 52 
diet during lactation programs reduced growth and appetite in offspring. 53 
 54 




Developmental programming describes the growth and nutritional patterns during early life 57 
that influence the risk of developing disease in later life (Bianco-Miotto et al, 2017). Postnatal 58 
overnutrition and rapid postnatal growth during early life are associated with long-term 59 
susceptibility to obesity in both humans and animal models (Ozanne and Hales, 2004; Rkhzaf-60 
Jaf et al, 2012). In contrast, slow growth during early postnatal life is linked to decreased 61 
obesity in later life (Jimenez-Chillaron et al 2006; Remmers et al, 2008; Stocker et al, 2012). 62 
Studies of short catastrophic famine conditions, such as the Dutch Hunger Winter and Chinese 63 
famines, provide natural experiments to directly examine the long-term health effects of 64 
profound nutritional changes at different stages of early life. Children, particularly males, born 65 
to mothers exposed to undernutrition in utero during early gestation showed an increased 66 
propensity to obesity; conversely, those exposed in the last trimester of pregnancy or in early 67 
postnatal life had a reduced risk of obesity as adults (Ravelli et al., 1976)).  68 
 69 
Reducing growth and weight gain during lactation in rodents similarly results in a permanent 70 
reduction in body weight and food intake, greater leanness when fed a chow diet, resistance to 71 
diet-induced obesity as well as improved insulin and leptin sensitivity (Ozanne and Hales, 72 
2004; Jiminez-Chilleron et al, 2006; Cripps et al, 2009). The precise molecular mechanisms 73 
linking altered nutrition in early life and long-term energy balance are still under investigation. 74 
However, programmed changes in the hypothalamus (Stocker et al, 2012; Wattez et al, 2013; 75 
Tungalagsuvd et al, 2016) and brown and white adipose tissue (Garcia et al, 2011; Claycombe 76 
et al, 2013, Palou et al, 2015) are implicated. 77 
 78 
The hypothalamus differentiates in utero, but continued maturation occurs into early postnatal 79 
life in both rodents and humans (Grove et al, 2005; Glavas et al, 2007). Studies in animal 80 
6 
 
models have shown that during this period the expression of neuropeptides and their receptors 81 
can be permanently altered by the maternal diet (Muhlhausler et al, 2006; Delahaye et al, 2008; 82 
Chen et al, 2008).  The arcuate nucleus of the hypothalamus (ARC) is a key homeostatic brain 83 
region modulating appetite and body weight (Heisler and Lam, 2017).  It has been reported that 84 
maternal dietary modification can modulate central serotonergic pathways and feeding 85 
behaviour in rats (Paradis et al, 2017) and the 5-HT1AR, 5-HT1BR and 5-HT2AR levels and 86 
receptor-mediated feeding behaviour are altered in rats exposed in utero to a maternal low 87 
protein diet (Lopes de Souza et al, 2008; Manuel-Apolinar et al, 2014; Martin-Gronert et al, 88 
2016). 5-HT receptors have long been demonstrated to directly affect food consumption and 89 
food-seeking behaviour (Blundell et al, 1995; Calu et al, 2014; D’Agostino et al, 2018) and 90 
have been proposed as targets for anti-obesity therapies (Burke and Heisler, 2015). The aim of 91 
the current study was therefore to investigate the effect of a maternal low protein diet during 92 
the suckling period (undernutrition) on the mechanisms of 5-HT-mediated food intake. 93 
 94 
Materials and Methods 95 
Experimental groups and tissue collection 96 
All procedures involving rats were conducted following approval by the University of 97 
Cambridge and the University of Buckingham Ethical Review Processes and in accordance 98 
with project licences under the British Home Office Animals (Scientific Procedures) Act 99 
(1986). The breeding of  Wistar rats (Charles River, Ltd, Margate, United Kingdom) was 100 
conducted at both the University of Cambridge (for laser-capture microdissection (LCM) and 101 
the University of Buckingham (for for intracerebroventricular (i3v) studies). Detailed 102 
information regarding the diet composition and the set-up of the maternal protein restricted 103 
(8% protein) and Control dams have been published previously (Petry et al, 1997; Cripps et al, 104 
2009; Stocker et al, 2012). The day after birth (P1) two experimental groups of offspring were 105 
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established: Controls [offspring of Control dams, culled to 8 (four males and four females) 106 
suckled by Control dams], and postnatal low protein [PLP; offspring of dams (4 males and 4 107 
females) fed Control diet during pregnancy, but nursed by low protein dams]. The body weight 108 
of the pups was recorded at P1, P7, P14 and P21. Following weaning at day 21, all male pups 109 
were fed standard laboratory chow and body weight and food intake recorded weekly. One 110 
male pup per litter was culled at P7, 14 and 22 for serum and their hypothalami dissected. At 111 
3 months of age the remaining males were culled, and their brains collected. All the dissected 112 
brains and hypothalami were frozen on powdered dry ice and were stored at - 80°C until further 113 
processing.  114 
   115 
Laser Capture Microdissection (LCM) and RNA isolation 116 
Hypothalamic sections of the arcuate nucleus (n=6 Control and n=6 PLP each from a different 117 
litter) were prepared as described previously (Martin-Gronert et al, 2016). Specifically, the 118 
ARC was sectioned on a cryostat at 14µm thickness from approximately -4.52 to -2.30 mm 119 
relative to the bregma (Paxinos and Watson, 1998). Sections were collected onto RNase-free 120 
membrane-coated slides (P.A.L.M) that had been baked at 200oC for 4 hours and UV cross-121 
linked for 30 minutes. On average 10 sections were collected per slide (in one movement) and 122 
18-20 slides were obtained per brain. Within 24 hours of sectioning, sections were placed for 123 
30 seconds each time in 95% ethanol, and then in 75% and 50% ethanol for rehydration. 124 
Sections were stained with 1% cresyl violet stain (Ambion, Foster City, California, USA) for 125 
1 minute, dehydrated in graded ethanol concentrations (50%, 75% and twice in 100% for 30 s 126 
each time), HistoClear (National Diagnostics (Atlanta, Georgia, USA) for 5 minutes and air 127 
dried. LCM was performed using a P.A.L.M. MicrolaserSystem (P.A.L.M. Microlaser 128 
Technologies, Burkhardtsdorf, Germany). Following microdissection, the captured cells were 129 
kept in RNAlater (Ambion). Total RNA was isolated from LCM samples using the 130 
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RNAqueous Micro RNA extraction kit (Ambion) in accordance with the manufacturer’s 131 
protocol. The quality and quantity of the RNA samples was determined using the Agilent 132 
BioAnalyzer PicoChips (Agilent Technologies Inc, Santa Clara, California, USA). 133 
RNA amplification  134 
Ovation Pico RNA Amplification System (Nugen Technologies Inc, San Carlos, California, 135 
USA) was used for the amplification of RNA destined for microarray analysis. RNA 136 
amplification of LCM ARC samples (n=6 Control and n=6 PLP each from a different litter) 137 
used to validate genes identified by microarray analysis was performed using a MegaScript T7 138 
Amplification Kit (Ambion) in combination with the GeneChip sample CleanUp Module kit 139 
(Affymetrix Inc, Santa Clara, California, USA). The use of a different method of RNA 140 
amplification enhanced the validation of the microarray data. 141 
 142 
Microarray hybridization 143 
The amplified RNA was used for gene expression profiling on Affymetrix Rat Genome 230 144 
2.0 Arrays (Affymetrix Inc) using the Affymetrix GeneChip protocol to fragment and label the 145 
target, ready for hybridization to the arrays. GeneChip sequences were selected from GenBank, 146 
dbEST and RefSeq and the sequence clusters created using UniGene were then further refined 147 
by comparison with the publicly available assembly of the rat genome. Microarray 148 
hybridization was carried out by Molecular Biology Services at University of Warwick, using 149 
n=6 chips per group (each from a different litter). The Control array data is the same as that 150 
used in our previous paper and the PLP array was run in parallel (Martin-Gronert et al., 2016). 151 
 152 
Microarray analysis and selection of the genes for validation 153 
Raw image data files were converted to CEL and pivot files using Affymetrix GeneChip 154 
Operating Software (GCOS). All downstream analysis of microarray data was performed using 155 
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GeneSpring GX 12.0 (Agilent). The CEL files were used for the Robust Multi-array Averaging 156 
(RMA) (Irizzarry et al, 2003) and GeneChip RMA (GC-RMA) (Wu et al, 2004) analyses, while 157 
the pivot files were used for GCOS analysis. After importing the data (n=6 Control and n=6 158 
PLP each from a different litter), each chip was normalized to the 50th centile of the 159 
measurement taken from that chip and all gene expression data reported as a fold-change from 160 
the control state. Genes were considered to be up- or downregulated if the genes had differential 161 
expression of P<0.05 in comparison to the Control group, if 1.3-fold threshold was reached 162 
(statistical criterion described previously in Martin-Gronert et al, 2016). Only genes that met 163 
the above criteria using GCOS, RMA and GCRMA were taken forward for additional study. 164 
The further selection of genes for validation was based on the function of the gene and the 165 
availability of suitable primers for validation. Potential consequences of gene expression 166 
dysregulation were gained from Ingenuity Pathway Analysis (Ingenuity Systems Inc.). Data 167 
have been deposited in Gene Expression Omnibus (accession number GSE76012) at 168 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE76012. 169 
 170 
Validation of microarray data using Taqman RT-PCR  171 
Validation of the microarray data was carried out using Micro Fluidic Cards (Applied 172 
Biosystems, Foster City, CA, USA) in accordance with the manufacturer’s protocol (Applied 173 
Biosystems). The reactions were performed in duplicate for each sample using an ABI 7900HT 174 
(Applied Biosystems). A standard curve was constructed for each gene using a serial dilution 175 
of pooled cDNA from all LCM ARC samples. The mean CT values of the experimental samples 176 
were then used to calculate the relative expression for each sample and data were normalized 177 
to Ppia (cyclophilin), expression of which did not change between postnatal maternal treatment 178 
groups. RNA from the hypothalamus of 3-month-old rats was used for gene expression 179 
analyses with GAPDH as an internal control. Real time PCR (StepOneTM, Applied Biosystems) 180 
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was carried out using Assay on Demand pre-designed primer and probe sets (Applied 181 
Biosystems) (n=8 control and n=8 PLP). Data were analysed using the comparative ΔCt 182 
method, comparing PLP rats with Controls. All procedures were carried out in accordance to 183 
the manufacturer’s recommendation and the genes assayed are listed in Table 1.  184 
 185 
Effects of centrally administered compounds on food intake 186 
Male and female rats (n=21 Control and n=29 PLP) were cannulated as described previously 187 
(Stocker et al, 2012). A cannula was inserted into the third ventricle under gaseous anaesthetic 188 
(isoflurane: Isoba, Schering-Plough Animal Health, Kenilworth, New Jersey, USA) using 189 
coordinates from the stereotactic rat brain atlas (Paxinos and Watson, 1998). Its position was 190 
verified by a positive drinking response over 15 minutes to angiotensin II (50 ng in 2.5 µl). For 191 
measurements of acute effects on food intake of d-fenfluramine, 5-HT5AR agonism, 5-HT2CR 192 
agonism alone or in combination with a selective 5-HT5AR antagonist, if administered the 193 
antagonist, it was dosed 15 minutes prior to the agonist.  3-month-old rats were individually 194 
housed, fasted for 4 hours prior to the onset of dark, dosed at the beginning of the dark period, 195 
food returned, and intake recorded 1, 2 and 4 hours post-dosing. A similar procedure was 196 
followed for NPY and 5-HT5AR agonist combination studies, except that NPY was 197 
administered 30 minutes after the dose of the 5-HT5AR agonist at the beginning of the light 198 
cycle. Rats were dosed using a within-subjects procedure with a Latin square design to identify 199 
drug dose treatment order. Doses were separated by at least 4 days and normal feeding 200 
behaviour and body weight was restored prior to administration of the next dose. The 201 
specificity and doses of d-fenfluramine, the combination of 5-HT1R/5-HT5R/5-HT7R agonist 202 
5-carboxamidotryptamine maleate (5-CT) and selective 5-HT5AR antagonist SB699551, the 203 
high affinity 5-HT2CR agonist CP 809101 hydrochloride (2-[(3-Chlorophenyl)methoxy]-6-(1-204 
piperazinyl)pyrazine hydrochloride)  (Tocris Biosciences, Bristol, UK) and NPY (Bachem, St 205 
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Helens, UK) were based on published data (Muñoz-Islas et al, 2014; Siuciak et al 2007; 206 
Jourdan et al, 2003; Nikiforuk et al 2016; Martin-Gronert et al 2016; Stocker et al., 2012). 207 
Drug was delivered in 2.5 µl saline or DMSO as indicated.   208 
 209 
Statistical analysis 210 
Student’s t-test was used for statistical analysis unless otherwise stated. A priori power analysis 211 
was conducted using G*Power3 (Faul et al, 2007). Fractional growth rates were calculated 212 
using the formula: fractional growth rate = (current - starting weight)/ (period x starting 213 
weight). Total Quantitative Real-Time PCR gene expression data was normalized to Ppia. One-214 
and two-way ANOVA was used for the analysis of the food intake data. All data sets passed 215 
the Anderon-Darling test for normality of distribution (alpha of 0.05). Outliers as identified by 216 
ROUT were excluded (Motulsky and Brown, 2006). All litters were represented in the results. 217 
Offspring from each litter was selected randomly. Animals were randomly allocated by the 218 
Project Licensee, not the principle investigator. The data are presented as mean ± SEM values 219 
unless otherwise stated. P<0.05 was used to signify statistical significance. Vairiances were 220 
similar between all statistically compared groups. The study has been perfomed once. 221 
 222 
Results 223 
PLP rats are hypophagic and have reduced body weight 224 
PLP rat pups were smaller than Controls by day 7 (9.2 ± 0.2g versus 16.1 ± 0.3g; P<0.0001) 225 
and remained smaller throughout lactation, weighing 66% less than Controls at day 21 (17.4g 226 
± 0.4g versus 51.8 ± 1.0g; P<0.0001) (Figure 1A). At 3 months of age, PLP offspring 227 
consumed less food (23.1 ± 1.2 g.animal-1.day-1 vs. 29.5 ± 1.6 g.animal-1.day-1; P<0.001), 228 
gained less weight (P<0.001; Figure 1B) and had a lower body weight compared to Controls 229 
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(P<0.001; Figure 1B). At the age of 22 days there was no difference in the absolute brain 230 
weight between the PLP rats and Controls (Figure 1B. However, the weight of the brain was 231 
significantly higher in PLPs as a proportion of body weight (P<0.001) indicating that the 232 
growth of the brain was spared (Figure 1B). The sparing of the brain in the PLP rats was also 233 
apparent at three months of age (P<0.001; Figure 1B). 234 
 235 
Genes upregulated and downregulated in the ARC of PLP rats 236 
ARC microarray data were analysed using three different methods: GCOS, GC-RMA and 237 
RMA (Figure 2). The three analyses revealed that 97 genes were upregulated, and 149 genes 238 
were downregulated in the ARC of PLP rats compared to Controls. The top 25 upregulated 239 
(Table 2) and downregulated genes (Table 3) were ranked according to fold change. Of the 240 
upregulated genes, 11 are involved in neuronal proliferation, regeneration, development, 241 
differentiation or remodeling. 12 are responsible for generic neuronal or epididymal structural 242 
or molecular function. 2 of the upregulated genes are directly involved in neurotransmission: 243 
Grm7, a glutamate receptor involved in most aspects of brain function; and Htr5a, the 5-244 
hydroxytryptamine receptor 5A. Of the downregulated genes, 9 are repressors of cell growth 245 
and differentiation or inducers of neural degeneration/apoptosis. 11 are responsible for generic 246 
neuronal or epididymal structure or molecular function, including modulators of the blood 247 
brain barrier. Plau, Cry2 and Serpinb1a are components circadian rhythm. Igsf11 is an 248 
immunoglobulin highly expressed in the brain. Angptl4 (an LPL inhibitor in the periphery) is 249 
centrally expressed mainly in the glial cells and influences central control of whole-body 250 
metabolism. Angptl4 has been positively correlated with obesity and the metabolic syndrome, 251 
and both type 1 and type 2 diabetes (Vienberg et al, 2014). 252 
Of these, the eleven genes previously reported to be associated with central regulation of 253 
adiposity and nutritional energy balance were selected to be validated by real-time PCR. The 254 
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two genes identified by transcriptional profiling as upregulated in PLP rats selected to be 255 
validated by PCR were the serotonin 5A receptor Htr5a (5-HT5AR; P<0.05) and the rho 256 
guanine nucleotide exchange factor Kalrn (P<0.05) (Figure 3). Out of the genes that were 257 
predicted to be downregulated in the ARC of the PLP group, nine were selected for validation. 258 
Out of these, three genes were expressed at very low levels, below the threshold of sensitivity 259 
of our assay (Plau, Gbp2 and Cp). One gene (Cry2) was not different between groups as 260 
measured by PCR (100 ± 16.1 for Controls versus 110.1 ±  18.3  (% mean Control) for  PLP).  261 
Rest was one of the top genes downregulated in PLP rats (Figure 3).  Cdk5R1 (Cdk5/p35), 262 
Dok1, Txnip were also significantly downregulated. RT-PCR confirmed that all these 263 
transcripts were reduced in the PLP rats in comparison to the Controls including Rest (P=0.07), 264 
Cdk5R1 (P<0.01), Dok1 (P<0.05) and Txnip (P<0.05).  The overall validation rate by PCR 265 
was 86%. 266 
 267 
PLP rats are more sensitive to 5-HT obesity medication d-fenfluramine 268 
A key effect of maternal PLP is lifelong reduced food intake and body weight in offspring.  5-269 
HT is an established neurotransmitter modulating feeding and body weight.  Taking advantage 270 
of this biological effect, medications augmenting 5-HT bioavailability have been used to affect 271 
human feeding and body weight over the past few decades, such as the global obesity 272 
medication d-fenfluramine (Burke and Heisler, 2015).  273 
 274 
To investigate whether changes in 5-HT circuitry might underpin PLP rats reduced feeding 275 
behaviour and body weight, we began by measuring hypothalamic 5-HT levels.  No differences 276 
in hypothalamic 5-HT was detected between Control (1354+86 pmol.g-1; n = 12) and PLP 277 
(1415+139 pmnol.g-1; n = 12) offspring.  We next stimulated the release of endogenous 5-HT 278 
and blocked its reuptake with d-fenfluramine.  D-fenfluramine was administered directly into 279 
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the third ventricle and food intake recorded in 3-month-old PLP and Control rats.  D-280 
fenfluramine significantly suppressed food intake in both Control and PLP rats (Figure 4).  281 
However, PLP rats were significantly more sensitive to d-fenfluramine compared to Controls 282 
(P<0.05) 2 hours post dosing.  These data suggest that PLP may impact 5-HT brain circuitry 283 
modulating energy homeostasis. 284 
 285 
PLP rats are more sensitive to the anorectic effect of 5-CT 286 
5-HT2CR is the primary 5-HT receptor in the ARC that mediates both 5-HT and d-287 
fenfluramine-induced reduction in food consumption (Heisler et al., 2002).” (Heisler et al., 288 
Science 2002). However, we detected no differences in ARC 5-HT2CR expression in PLP 289 
compared to Control rats, suggesting that action at this receptor is unlikely to explain the 290 
differences in sensitivity to d-fenfluramine. We investigated a functional difference in 5-291 
HT2CR agonist responsivity by administering CP 809101 or vehicle into the third ventricle and 292 
measuring food intake. No overall significant difference was detected in the feeding response 293 
to CP 809101 between the Control and PLP groups when compared by 2-way ANOVA (Figure 294 
5A-B).  These findings illustrate that PLP rats are not broadly more sensitivity to compounds 295 
that reduce feeding.  296 
 297 
D-fenfluramine will increase endogenous 5-HT activity at all receptors and we found that ARC 298 
5-HT5AR expression is increased with PLP diet. Like d-fenfluramine, partial 5-HT5AR agonist 299 
5-CT suppresses food intake (Martin-Gronert et al, 2016). To investigate how changes in 5-300 
HT5AR gene expression in PLP rats might influence food intake, we administered 5-CT into 301 
the third ventricle and measured its effects on food intake. Similar to d-fenfluramine,  PLP 302 
offspring were more sensitive to the anorectic effect of 5-CT compared to Controls one hour 303 
(P<0.01; Figure 5C) and two hours after dosing (P<0.05; Figure 5D). To confirm the specificity 304 
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at the 5-HT5AR we performed a combination study with 5-CT and a specific 5-HT5AR 305 
antagonist SB699551. SB699551 (30 nmol) significantly blocked the effect of a half-maximal 306 
dose of 5-CT of 5 nmol in PLP and 10 nmol in Control offspring (Figure 5E-F).  These data 307 
suggest that the upregulation of ARC 5-HT5ARs in PLP rats increases sensitivity to the feeding 308 
effect of 5-HT5AR agonism. 309 
 310 
5-CT reduces the orexigenic effect of Neuropeptide Y 311 
NPY is a potent stimulator of hunger and one of the brain regions of NPY expression is the 312 
ARC. To investigate specifically how the changes in 5-HT5AR gene expression might influence 313 
central mechanisms of food intake, we administered the partial 5-HT5AR agonist 5-CT directly 314 
into the third ventricle and measured its effects on NPY-induced food intake in adult 3-month-315 
old offspring.  A half-maximal dose of NPY was used based on previous studies (Stocker et al, 316 
2012) and this was confirmed here. 5-CT reduced the NPY-induced food consumption in both 317 




The quality of postnatal diet has a lifelong impact on offspring health, appetite and body 322 
weight. To gain insight into the mechanisms underpinning maternal diet programming of 323 
dysregulated appetite and body weight, here we examined a key homeostatic brain region 324 
essential for the normal regulation of feeding behaviour, the ARC. ARC microarray identified 325 
the 5-HT system as one of the most affected targets in PLP offspring. 5-HT has been implicated 326 
in programming and regulation of hyperphagia and obesity in rat and mice offspring from dams 327 
undernourished during pregnancy (Lopes de Souza et al, 2008; Martin-Gronert et al, 2016; 328 
Manuel-Apolinar et al, 2014). Conversely, rats from mothers fed low protein diet during the 329 
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postnatal suckling period exhibit hypophagia and resistance to obesogenic diets and this study 330 
investigated this in relative to the 5-HT system. The maternal 8% protein diet during lactation 331 
reduced offspring body weight, particularly during the suckling period. However, other than 332 
being smaller there were no adverse effects associated with this severe malnutrition such as 333 
increased mortality. This corresponds to previous reports that show 8% protein diet-fed dams 334 
displayed lactational deficiency resulting in reduced postnatal growth and modulated 335 
peripheral metabolism, but no other overt symptoms of malnutrition as generated by lower 336 
protein levels (Resnick et al, 1982; Miller et al, 1980; Gabr, 1981). Resnick (Resnick et al, 337 
1982) concluded that the 8% protein model is useful for studying “hidden” forms of 338 
malnutrition in man (Resnick et al., 1982). The lack of data in female offspring is a limitation 339 
of this study given the growing recognition of sex differences in programming (Dearden et al., 340 
2018) and future studies should incorporate this factor in their design. 341 
 342 
Relative to body weight, food intake in the PLP offspring was 7.53% of body weight compared 343 
with 7.07% in the controls. However, fat has less metabolic activity than lean tissue; possibly 344 
as little as one sixth relative to weight (Arch and Trayhurn, 2013), so the food intake of the 345 
PLP offspring may be what would be predicted from their body weight and composition. 346 
Unfortunately, we do not have body composition data, which is a limitation of the study.  347 
 348 
This raises the cause-and-effect relationship between the effects of the PLP diet on food intake 349 
and on body weight and composition. If the PLP diet drives changes in body weight and 350 
composition by reducing long-term food intake, it is to be expected that energy intake will 351 
stabilise at a level that is very close to that predicted from body weight and composition. Obese 352 
and lean subjects fall on the same regression lines that link energy expenditure to body weight 353 
and composition, and only small imbalances in energy intake and energy expenditure are 354 
17 
 
required for obesity (or leanness) to develop over time (Arch and Trayhurn, 2013). An 355 
alternative perspective is that the primary effect of the PLP diet may be on body weight and 356 
composition, with food intake per mouse being reduced, by the mechanisms elucidated in the 357 
present study, to accommodate the reduced metabolic demands of the PLP offspring. Others 358 
have similarly raised the cause-and-effect relationship between overeating and obesity 359 
(Ludwig and Friedman, 2014).  360 
 361 
Of the seven 5-HT receptor families and fourteen receptor subtypes, 5-HT2 is the predominant 362 
family associated with appetite, particularly 5-HT2CR (Heisler et al, 2002; Lam et al, 2010). 363 
Additionally, 5-HT1AR, 5-HT1BR and 5-HT4R agonism have been associated with decreased 364 
appetite (Kumar et al, 2010; Jean et al, 2012) and 5-HT6R associated with overeating (Pratt et 365 
al, 2009). 5-HT5ARs are implicated in psychiatric behaviour (Kassai et al, 2012), have been 366 
associated with plasma triglyceride availability (Zhang et al, 2010) and food-seeking initiation 367 
(Pickens et al, 2012). Recently it has been discovered that maternal dietary modification can 368 
cause profound changes within the rat hypothalamus that affect food consumption (Stocker et 369 
al, 2012; Wattez et al, 2013; Tungalagsuvd et al, 2016) and 5-HT receptors, among other 370 
factors, have been implicated in these changes (Paradis et al, 2017). 371 
 372 
In this study, 5-HT5AR agonism with 5-CT significantly suppresses food intake in Control rats 373 
and in PLP offspring. The relative effect was greater in PLP offspring than in Control rats with 374 
the effect being completely reversed by the 5-HT5AR antagonist, SB699551. Whilst 5-CT has 375 
highest affinity with the rat 5-HT5AR it also agonizes 5-HT1R and 5-HT7R families (Nelson, 376 
2004). However, the lack of overlap in activity of 5-CT and the specific 5-HT5AR  antagonist, 377 
SB699551 (Muñoz-Islas et al, 2014), coupled with the gene expression differences suggests 378 
that it is the 5-HT5AR that is responsible for the differences observed in 5-HT-mediated 379 
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inhibition of food consumption. The lack of a demonstrable difference between the groups in 380 
5-HT2CR action is consistent with the suggestion that it is the 5-HT5AR that is the main subtype 381 
affected in the offspring of dams fed a low protein diet during the postnatal period. 382 
 383 
In addition to the 5-HT5AR gene expression upregulation we identified several genes involved 384 
in homeostasis and neuronal development in the ARC of PLP rats that were permanently 385 
expressed at a lower level because of maternal protein restriction during lactation. Rest is a 386 
transcriptional repressor that is critical for neurogenesis and neuronal differentiation and 387 
plasticity (Chen et al., 1998). REST has been found to induce de-repression of the 5-HT1AR 388 
gene (Lemonde et al, 2004), although its influence on other 5-HT receptor subtypes has yet to 389 
be investigated. Cdk5R1 (Cdk5/p35) is a key regulator of neuronal cytoskeleton and an 390 
important determinant of neuronal death/survival signals (Dhariwala and Rajadhyaksha, 2008) 391 
and has been previously associated with a preference for high calorie food intake in mice 392 
exposed in utero to a maternal high fat diet (Teegarden et al, 2009). Dok1 plays a role in 393 
immunoreceptor signalling (Mashima et al., 2009) and has been implicated in the development 394 
of obesity (Hosooka et al., 2008). Txnip is an essential component of a redox signalling 395 
pathway, through which it mediates oxidative stress responses (Schulze et al., 2004) and cell 396 
proliferation (Rani et al., 2010). Txnip null mice are resistant to obesity-associated insulin 397 
resistance (Chutkow et al, 2010). It has also been linked to growth, development and 398 
differentiation of the brain, central leptin sensitivity, regulation of energy balance and the 399 
development of diabetes (Levendusky et al, 2009; Chen et al, 2008; Lappalainen et al., 2009; 400 
Blouet et al., 2012) and may contribute to lower body weight, resistance to diet-induced obesity 401 




In conclusion, maternal low protein diet during the suckling period was associated with of 97 404 
upregulated and 149 downregulated genes in the homeostatic brain region the ARC in PLP rats 405 
compared to Controls.  The ARC is an essential regulator of appetite and PLP mice exhibit 406 
lifelong reduced feeding and body weight. Of particular interest was an upregulation of 5-407 
HT5ARs because increases in 5-HT bioavailability is established to decrease feeding rodents 408 
and humans.  PLP offspring were also more sensitive to the anorectic effect of endogenous 5-409 
HT, as stimulated by d-fenfluramine and 5-HT5AR agonism. These data suggest that PLP 410 
programs a greater number of ARC 5-HT5ARs which are positioned to respond to 5-HT’s 411 
regulation of feeding behaviour.  This may contribute to the effect of PLP to maintain reduced 412 
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Figure Legends 644 
 645 
Figure 1. Growth trajectory and brain weights of Control and PLP rats. A, Growth 646 
trajectory throughout the suckling period illustrates lower body weight in postnatal low protein 647 
(PLP) rats when compared to age-matched Controls. B, Body weight and brain weights at 648 
postnatal day 22 (P22), 3-11 weeks and 3 months (3M) of age in PLP and Control rats 649 
illustrated reduced body weight, but not brain weight, in PLP rats. Statistical analysis by 2-way 650 
ANOVA followed by Sidak’s multiple comparisons test (n =10 per group).  651 
P<0.0001,***P < 0.001.  Values are expressed as means ± S.E.M. 652 
 653 
Figure 2. Venn diagrams of maternal protein restriction during lactation on ARC gene 654 
expression in 3-month-old male offspring according to three different analyses: GCOS, 655 
GC-RMA and RMA. 97 genes were upregulated, and 149 genes were downregulated in 656 
postnatal low protein (PLP) rats when compared to Controls (C). The sizes of circles and 657 
numbers in parentheses indicate the number of genes as identified by either the GCOS, RMA 658 
or GC-RMA algorithms.  659 
 660 
Figure 3. RT-PCR validation of the differentially expressed genes in the ARC of Control 661 
and postnatal low protein (PLP) rats identified with microarray. Analysis carried out 662 
using RT-PCR. Gene expression was normalized to housekeeping Control Ppia. Values are 663 
expressed as means ± S.E.M. (n=8 per group). Data were analysed using a one-tailed 664 
unpaired Student’s t-test.  * P<0.05; ** P<0.01.  Values are expressed as means ± S.E.M. 665 
Figure 4. PLP rats are more sensitive to the anorectic effect of d-fenfluramine. Food intake 666 
was measured 2 hours after third ventricle administration of 250 nmol d-fenfluramine (DEX) 667 
or vehicle (VEH) to 3-month-old Control (n=20) and postnatal low protein (PLP; n=20) rats. 668 
26 
 
P<0.05; P<0.01; P<0.0001, for food intake differences as a percentage of 669 
saline, between Control and PLP rats. Values are expressed as means ± S.E.M. 670 
 671 
Figure 5. Enhanced 5-HT-induced food intake in PLP rats is 5-HT5AR-mediated. Food 672 
intake was measured A, 1 and B, 2 hours after administering the 5-HT2CR agonist CP 809101 673 
to 3-month-old Control and postnatal low protein (PLP) rats (n=17 to 18 per group). Food 674 
intake was measured C, 1 and D, 2 hours after administering the 5-HT5AR agonist 5-CT to 3-675 
month-old Control and PLP rats (n=12 to 16 per group). Statistical analysis of each time 676 
point was by 2-way ANOVA followed by Sidak’s multiple comparisons test,  P<0.01, 677 
 P<0.001. Food intake following central administration of a submaximal dose of the 5-678 
HT5AR agonist 5-CT and a selective 5-HT5AR antagonist SB699551 was measured E, 1 and 679 
F, 2 hours after administering 5-CT with or without 30 nmol SB699551 to 3-month-old 680 
Control and PLP rats (n=11 to 16 per group). P<0.05; P<0.01;  P<0.001. Values 681 
are expressed as means ± S.E.M.Values are expressed as means ± S.E.M. 682 
 683 
Figure 6. Effect of 5-HT5AR agonist 5-CT combined with NPY on food intake. Food intake 684 
was measured 2 hours after administering 5-CT with the half-maximal dose of NPY to 3-685 
month-old Control (n=21) and PLP rats (n=20 to 29 per group). P<0.001. Values are 686 
expressed as means ± S.E.M. 687 
 688 
Table 1. Genes assayed by PCR. 689 
 690 
Table 2. Top 25 genes increased in the ARC of PLP offspring compared to Controls.  691 
















Figure 1. 706 Growth 
trajectory 707 and brain 
weights of 708 Control 
and PLP 709 rats. 
 710 
 711 
  712 
 Control          PLP 
Body weight (g) at 3M        417 ± 9.0     306.6 ± 11.1 *** 
Body weight gain (g) 3-11 wks      377.3 ± 5.8      297.4 ± 6.8   ***  
Brain weight (g) at P22   1.44 ± 0.2            1.20 ± 0.2     
Brain weight (% of BW) at P22       2.69 ± 0.23       6.00 ± 0.25 *** 
Brain weight (g) at 3M   2.00 ± 0.3            1.78 ± 0.3      
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Figure 2. Venn diagrams of maternal protein restriction during lactation on ARC gene 727 
expression in 3-month-old male offspring according to three different analyses: GCOS, 728 
GC-RMA and RMA.  729 
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Figure 3. RT-PCR validation of the differentially expressed genes in the ARC of Control 736 



















Figure 4. PLP rats are more sensitive to the anorectic effect of d-fenfluramine.  754 
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Figure 5. Enhanced 5-HT-induced food intake in PLP rats is 5-HT5AR-mediated.  759 







Figure 6. Effect of 5-765 
HT5AR agonist 5-CT 766 
combined with NPY on 767 
food intake.  768 
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Table 2. Top 25 genes increased in the ARC of PLP offspring compared to Controls.  773 
Probe Set ID Fold 
Change 
Gene Symbol Gene Title 
1397955_at 1.90 Rtel1 regulator of telomere elongation helicase 1 
1379905_at 1.80 Gtpbp1 GTP binding protein 1 
1379128_at 1.79 Arhgef17 Rho guanine nucleotide exchange factor (GEF) 17 
1370643_at 1.77 Kalrn kalirin, RhoGEF kinase 
1384502_at 1.63 Fbxo42 F-box protein 42 
1382037_at 1.47 Crim1 cysteine rich transmembrane BMP regulator 1 (chordin like) 
1369781_at 1.45 Grm7 glutamate receptor, metabotropic 7 
1378424_at 1.44 Trim46 tripartite motif-containing 46 
1373677_at 1.43 Slc39a10 solute carrier family 39 (zinc transporter), member 10 
1391208_at 1.42 Pcdh20 protocadherin 20 
1387850_at 1.41 Tmeff1 transmembrane protein with EGF-like & two follistatin-like domains 1 
1385801_at 1.40 Dnajc18 DnaJ (Hsp40) homolog, subfamily C, member 18 
1391600_at 1.38 Mga MAX gene associated 
1371027_at 1.37 Cblb Cas-Br-M (murine) ecotropic retroviral transforming sequence b 
1378269_at 1.37 Dnalc1 dynein, axonemal, light chain 1 
1398125_at 1.37 Ank2 ankyrin 2, neuronal 
1369463_at 1.36 Htr5a 5-hydroxytryptamine (serotonin) receptor 5A 
1394599_at 1.36 Zxdc ZXD family zinc finger C 
1386049_at 1.36 Kctd4 potassium channel tetramerisation domain containing 4 
1377714_at 1.35 Pvrl3 Poliovirus receptor-related 3 
1397224_at 1.35 Atp2b1 ATPase, Ca++ transporting, plasma membrane 1 
1387920_at 1.35 Man2c1 mannosidase, alpha, class 2C, member 1 
1381205_at 1.35 Snapc5 Small nuclear RNA activating complex, polypeptide 5 
1392942_at 1.35 RGD1563325 similar to hypothetical protein MGC17943 
1368497_at 1.34 Abcc2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 
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Table 3. Top 25 genes decreased in the ARC of PLP offspring compared to Controls.  775 
Probe Set ID Fold 
Change 
Gene Symbol Gene Title 
1387675_ at 2.05 Plau plasminogen activator, urokinase 
1388086_ at 1.91 Rest RE1-silencing transcription factor 
1373006_at 1.86 Tmem171 transmembrane protein 171 
1369056_at 1.84 Rpe65 retinal pigment epithelium 65 
1398621_at 1.82 Ak7 adenylate kinase 7 
1368332_at 1.79 Gbp2 guanylate binding protein 2 
1369446_at 1.75 Cry2 cryptochrome 2 (photolyase-like) 
1388924_at 1.72 Angptl4 angiopoietin-like 4 
1395184_at 1.71 Clec12a  C-type lectin domain family 12, member A 
1368028_at 1.71 Prph peripherin 
1389123_at 1.69 Ccl6 chemokine (C-C motif) ligand 6 
1377034_at 1.68 Serpinb1a serine (or cysteine) proteinase inhibitor, clade B, member 1a 
1382284_at 1.66 Nek3 NIMA (never in mitosis gene a)-related kinase 3 
1388762_at 1.65 Iqgap1 IQ motif containing GTPase activating protein 1 
1368418_ at 1.65 Cp ceruloplasmin 
1379068_at 1.63 Armc9 armadillo repeat containing 9 
1397424_at 1.62 Synpo2 Synaptopodin 2 
1385292_at 1.62 Sc65 Synaptonemal complex protein SC65 
1381979_at 1.60 Sumf2 sulfatase modifying factor 2 
1369538_at 1.60 Cdk5r1 cyclin-dependent kinase 5, regulatory subunit 1 (p35) 
1371447_at 1.59 Plac8 placenta-specific 8 
1391776_at 1.57 RGD1305283 COX assembly mitochondrial protein homolog (S. cerevisiae) 
1372254_at 1.56 Serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 
1376733_at 1.56 Igsf11 immunoglobulin superfamily, member 11 
1384292_at 1.47 Dok1 docking protein 1 
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